Clinical Trials Search Results

Patients & Visitors
- Patients & Visitors
  At UHN, we strive to deliver Compassionate Care & Caring. Learn more about the services and supports that are available to you throughout your journey.
- Getting to UHN
- Emergency Departments
- COVID Information
- Virtual Care at UHN
- Accessibility at UHN
- Find a Doctor
- myUHN Patient Portal
- Health Information
- Patient & Family Learning Centres
- Translation Services
- Patient Relations
- Patient Services
- Pay Your Bill
- Walk-Safe Program
Programs & Services
- Programs & Services
  Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
- Ajmera Transplant Centre
- Altum Health
- Centre for Mental Health
- Laboratory Medicine Program
- Krembil Brain Institute
- Joint Department of Medical Imaging
- Medicine Program
- Peter Munk Cardiac Centre
- Princess Margaret Cancer Centre
- Schroeder Arthritis Institute
- Surgery and Critical Care Program
- Toronto Rehab
- Social Medicine
- Women's Health Program
- Pharmacy Services
- Transplant Outpatient Pharmacy
Health Professionals
- Health Professionals
  At the heart of everything we do at UHN are our Healthcare Professionals. Refer a patient to one of our 12 medical programs. Learn more about the resources and opportunities available for professional growth.
- Refer a Patient to UHN
- Health Professions at UHN
- Observerships
Research at UHN
Education at UHN
- Education at UHN
  University Health Network has grown to be one of the largest research and teaching hospital networks in Canada - pioneers in improving the lives of patients. Our long history of health professions education at Toronto General, Toronto Western, Princess Margaret and Toronto Rehab hospitals has consistently advanced the science of education.
- Michener Institute of Education
- UHN Education
- Health Information
- Patient & Family Learning Centres

About UHN
- About UHN
  University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
- Updates from the CEO
- UHN at a Glance
- Publications
- Our History
- Governance and Leadership
- Purpose and Performance
- Quality and Patient Safety
- Fiscal Accountability
- Privacy & Accessing Information
- Social Medicine Program
- Greening at UHN
- General Services
- Doing Business with UHN
- UHN Event Calendar
- UHN International
- Accessibility
Get Involved
- Ways You Can Help
  Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
- Volunteer
- Participate
- Donate
Newsroom
- Newsroom
  The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It's also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
- News Stories
- Media Releases
- UHN Podcasts
- Social Media at UHN
- Videos
- Media Policies
- Contacts
TeamUHN
Careers
Contact

390570	72921			3/24/2023 11:04:34 PM	3/24/2023 11:04:34 PM	A Phase 1/2 Single Arm Open-Label Clinical Trial of Gavocabtagene Autoleucel (Gavo-cel) in of either Malignant Pleural/Peritoneal Mesothelioma (MPM), Serous Ovarian	STS_ListItem_GenericList			https://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research/Lists/PMCP Clinical Trials Data/AllItems.aspx	57	2						0	https://www.uhn.ca		False				https://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research	{5E1D6FEA-DFB5-4E35-898A-FB5FF464140D}			~sitecollection/_catalogs/masterpage/UHN/templates/PMCP_Item_Clinical_Trials.js	42	42
390433	73094			3/24/2023 11:10:50 PM	3/24/2023 11:10:50 PM	A Phase 1, Open-Label, Multicenter Trial Investigating the Safety, Tolerability, and Preliminary cell and adenocarcinoma) 8. Mesothelioma (pleural and peritoneal	STS_ListItem_GenericList			https://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research/Lists/PMCP Clinical Trials Data/AllItems.aspx	51	1						0	https://www.uhn.ca		False				https://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research	{69DAF378-DF18-4595-94F9-39B55A981DAE}			~sitecollection/_catalogs/masterpage/UHN/templates/PMCP_Item_Clinical_Trials.js	42	42
390416	54182			3/24/2023 11:02:41 PM	3/24/2023 11:02:41 PM	A Phase 1 Open Label, Multi-Arm, Multicenter Study of MK-4830 as Monotherapy and in Combination With Pembrolizumab for Participants With Advanced Solid Tumors	STS_ListItem_GenericList			https://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research/Lists/PMCP Clinical Trials Data/AllItems.aspx	36	2						0	https://www.uhn.ca		False				https://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research	{48534183-1023-4945-8D45-CBB846B359C0}			~sitecollection/_catalogs/masterpage/UHN/templates/PMCP_Item_Clinical_Trials.js	42	42
390368	21504			3/24/2023 10:59:40 PM	3/24/2023 10:59:40 PM	A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects Small Cell Lung Carcinoma - Mesothelioma - Thyroid Carcinoma	STS_ListItem_GenericList			https://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research/Lists/PMCP Clinical Trials Data/AllItems.aspx	14	3						0	https://www.uhn.ca		False				https://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research	{A05F7CFB-3FEA-459E-B1F3-A09BD71B2717}			~sitecollection/_catalogs/masterpage/UHN/templates/PMCP_Item_Clinical_Trials.js	42	42
390425	230107			3/24/2023 11:08:45 PM	3/24/2023 11:08:45 PM	A Phase 1 Trial of the ATR Inhibitor BAY 1895344 in Combination With Cisplatin and With Cisplatin Plus Malignant pleural mesothelioma - Small cell lung cancer	STS_ListItem_GenericList			https://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research/Lists/PMCP Clinical Trials Data/AllItems.aspx	2	2						0	https://www.uhn.ca		False				https://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research	{A2DF8BD8-1376-44EB-A478-41D1354E6AA6}			~sitecollection/_catalogs/masterpage/UHN/templates/PMCP_Item_Clinical_Trials.js	42	42
390596	118651			3/24/2023 11:10:03 PM	3/24/2023 11:10:03 PM	An Open-label, Multicenter, Dose Escalation Phase 1b Study to Assess the Safety and MTC), gastroesophageal cancer (GEC), mesothelioma, breast cancer (BC) and	STS_ListItem_GenericList			https://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research/Lists/PMCP Clinical Trials Data/AllItems.aspx	35	2						0	https://www.uhn.ca		False				https://www.uhn.ca/PrincessMargaret/Research/Cancer_Clinical_Research	{E5E39B7D-F663-406C-8667-A63A1EF8C899}			~sitecollection/_catalogs/masterpage/UHN/templates/PMCP_Item_Clinical_Trials.js	42	42

	~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js
	~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js
	~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js
	~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js
	~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js
	~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js
	~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js
	~sitecollection/_catalogs/masterpage/Display Templates/Search/Item_Default.js

Text Size

Last reviewed:

Last modified: 6/15/2021 11:04 AM